Cargando…
Pre-Clinical Studies of Epigenetic Therapies Targeting Histone Modifiers in Lung Cancer
Treatment options for lung cancer patients have been generally limited to standard therapies or targeted interventions which involve a small number of known mutations. Although the targeted therapies are initially successful, they most often result in drug resistance, relapse, and mortality. We now...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3766830/ https://www.ncbi.nlm.nih.gov/pubmed/24058902 http://dx.doi.org/10.3389/fonc.2013.00235 |